Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Neuroblastoma × ceritinib × Clear all

Phase

Phase 1 2 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5 Lung Neoplasms 3 Hematologic Neoplasms 3 Adenocarcinoma of Lung 2 Thyroid Carcinoma, Anaplastic 1 Noonan Syndrome 6 1 Neuroblastoma 1 Neoplasm Metastasis 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, B-Cell 1 Granuloma, Plasma Cell 1 Glioblastoma 1 Carcinoma, Pancreatic Ductal 1 Carcinoma 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 26 Etoposide 19 Doxorubicin 15 Temozolomide 14 Isotretinoin 14 Irinotecan 14 Carboplatin 14 Topotecan 13 Vincristine 12 Melphalan 11 3-Iodobenzylguanidine 11 Granulocyte-Macrophage Colony-Stimulating Factor 10 sargramostim 9 Radiotherapy 9 Cisplatin 9 naxitamab 8 Magnetic Resonance Spectroscopy 8 Filgrastim 8 dinutuximab 7 Thiotepa 7 Peripheral Blood Stem Cell Transplantation 7 X-Rays 6 Phantoms, Imaging 6 Antilymphocyte Serum 6 fludarabine phosphate 5 Tacrolimus 5 Specimen Handling 5 Nuclear Medicine Department, Hospital 5 Methylprednisolone 5 Granulocyte Colony-Stimulating Factor 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02559778 2026-02-20

PEDS-PLAN

Milton S. Hershey Medical Center

Phase 2 Recruiting

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡